QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
OTCMKTS:OROCF

Allkem (OROCF) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)
Free OROCF Stock Alerts
$6.80
+0.10 (+1.49%)
(As of 01/8/2024)
Compare
Today's Range
$6.70
▼
$6.80
50-Day Range
$6.80
▼
$6.80
52-Week Range
$5.34
▼
$11.66
Volume
1,900 shs
Average Volume
14,560 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisAnalyst ForecastsChartHeadlinesShort Interest
OROCF stock logo

About Allkem Stock (OTCMKTS:OROCF)

Allkem Limited engages in the production and sale of lithium and boron in Argentina. Its flagship project is the Olaroz Lithium Facility located in Jujuy province in northern Argentina. Allkem Limited was incorporated in 2005 and is headquartered in Brisbane, Australia.

OROCF Stock Price History

OROCF Stock News Headlines

January 4, 2024 | markets.businessinsider.com
Jefferies Keeps Their Hold Rating on Allkem Limited (OROCF)
December 27, 2023 | markets.businessinsider.com
Jefferies Reaffirms Their Hold Rating on Allkem Limited (OROCF)
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
December 20, 2023 | sg.finance.yahoo.com
Allkem shareholders set to vote on Livent's $10.6 bln merger bid
December 14, 2023 | finance.yahoo.com
Sal de Vida Project Financing increases to US$180M
December 14, 2023 | baystreet.ca
South America's Lithium Potential Sparks Global Competition Amid Renewable Energy Push
November 12, 2023 | morningstar.com
Allkem Ltd OROCF
November 1, 2023 | markets.businessinsider.com
Analysts Offer Insights on Consumer Goods Companies: Allkem Limited (OtherOROCF), Silgan Holdings (SLGN) and Boston Beer (SAM)
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
October 28, 2023 | markets.businessinsider.com
Hold Rating on Allkem Limited: Adjusted Estimates Amid Market Fluctuations and Cost Concerns
October 13, 2023 | uk.finance.yahoo.com
Orocobre Limited (OROCF)
September 26, 2023 | markets.businessinsider.com
Analysts Offer Insights on Consumer Goods Companies: Allkem Limited (OtherOROCF) and McDonald’s (MCD)
September 25, 2023 | msn.com
Livent: Lithium Upside
September 15, 2023 | proactiveinvestors.com.au
NickelSearch and Allkem collaborate to assess lithium potential at Carlingup; shares soar
August 24, 2023 | markets.businessinsider.com
RBC Capital Sticks to Their Buy Rating for Allkem Limited (OROCF)
August 24, 2023 | markets.businessinsider.com
RBC Capital Sticks to Their Buy Rating for Allkem Limited (OROCF)
August 22, 2023 | markets.businessinsider.com
Macquarie Remains a Buy on Allkem Limited (OROCF)
August 22, 2023 | markets.businessinsider.com
BMO Capital Keeps Their Hold Rating on Allkem Limited (OROCF)
August 3, 2023 | msn.com
Allkem (OROCF) Price Target Increased by 8.92% to 11.87
July 31, 2023 | markets.businessinsider.com
Analysts Offer Insights on Consumer Goods Companies: Mondelez International (MDLZ) and Allkem Limited (OtherOROCF)
July 31, 2023 | markets.businessinsider.com
RBC Capital Keeps Their Buy Rating on Allkem Limited (OROCF)
July 28, 2023 | msn.com
Allkem reports Q4 results
July 27, 2023 | markets.businessinsider.com
Citi Reaffirms Their Buy Rating on Allkem Limited (OROCF)
June 23, 2023 | markets.businessinsider.com
Macquarie Sticks to Its Buy Rating for Allkem Limited (OROCF)
June 6, 2023 | fool.com
Allkem (OTC: OROCF)
May 17, 2023 | markets.businessinsider.com
Analysts Are Bullish on These Materials Stocks: Allkem Limited (OROCF), Talga Group Ltd. (TLGRF)
May 16, 2023 | markets.businessinsider.com
Jarden Sticks to Its Buy Rating for Allkem Limited (OROCF)
See More Headlines
Receive OROCF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Allkem and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Fiscal Year End
6/30/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Basic Materials
Industry
Private households
Sub-Industry
N/A
Current Symbol
OTCMKTS:OROCF
CUSIP
N/A
CIK
N/A
Web
www.orocobre.com
Phone
(173) 064-3600
Fax
61-7-3720-8988
Employees
1,350
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.08
Current Ratio
2.52
Quick Ratio
2.23

Sales & Book Value

Annual Sales
$1.21 billion
Price / Sales
N/A
Cash Flow
$1.10 per share
Price / Cash Flow
6.16
Book Value
$8.96 per share
Price / Book
0.76

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
1.68
These 7 Stocks Will Be Magnificent in 2024 Cover
These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. Martin Perez de Solay (Age 53)
    MD, CEO & Director
    Comp: $1.69M
  • Mr. Christian Cortes BACC
    C.A., EMBA, Chief of Staff & Acting CFO
  • Mr. James Connolly
    Chief Technical Officer
  • Mr. Andrew Barber B.Sc.
    Chief Investor Relations Officer
  • Mr. John Sanders
    Chief Legal Officer & Joint Company Secretary
  • Mr. Richard Stacy Anthon B.A.
    BA, FAIM, L.L.B., L.L.M., LLB, M.A.I.C.D., M, Chief Corporate Development Officer
  • Mr. Christian Barbier M.Sc.
    Chief Sales & Marketing Officer
  • Ms. Illeana Freire
    Chief Human Resources Officer
  • Mr. Hersen Porta
    Head of Argentina Operations
  • Mr. Simon Michael Hay B.Sc. (Age 56)
    BSc (Hons), Grad Dip, MAICD, MAppSc, President of International Business

Key Competitors

View All Competitors

OROCF Stock Analysis - Frequently Asked Questions

Should I buy or sell Allkem stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allkem in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" OROCF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OROCF, but not buy additional shares or sell existing shares.
View OROCF analyst ratings or view top-rated stocks.

How have OROCF shares performed in 2024?

Allkem's stock was trading at $7.30 on January 1st, 2024. Since then, OROCF shares have decreased by 6.8% and is now trading at $6.80.
View the best growth stocks for 2024 here.

How do I buy shares of Allkem?

Shares of OROCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:OROCF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media